Neurocrine Biosciences
NBIX
#1330
Rank
A$24.58 B
Marketcap
A$244.49
Share price
-0.86%
Change (1 day)
28.06%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company